Pfizer’s Paxlovid fails as 15-day treatment for long COVID, study finds
By Michael Erman (Reuters) – A 15-day course of Pfizer’s COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long…
By Michael Erman (Reuters) – A 15-day course of Pfizer’s COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long…
(Reuters) – As Nvidia threatens to dethrone Microsoft as the world’s most valuable company, at least a few investors are…
By Siddharth Cavale BENTONVILLE, Arkansas (Reuters) – Initial public offerings of Walmart’s Flipkart marketplace and PhonePe digital payments platform could…
By Kanishka Singh WASHINGTON (Reuters) -Pro-Palestinian activists demanding an end to the war in Gaza and to American support for…